Inventor · disambiguated record
Michel Revel
Also filed as: REVEL MICHAEL · REVEL MICHEL
41 granted patents·9 pending applications·930 citations·filing 1980–2023
98Inventor score
Top patents by PatentIndex Score
50 records- 0195US5468609AProduction of interferonYEDA RES & DEV·Filed 1982·Granted Nov 21, 1995·92 cites·1 claims
- 0293US5541312AProduction of interferonYEDA RES & DEV·Filed 1982·Granted Jul 30, 1996·67 cites·7 claims
- 0392US5621077ASoluble IFN-β2/IL-6 binding protein its preparation, and pharmaceutical compositions containing itYEDA RES & DEV·Filed 1994·Granted Apr 15, 1997·90 cites·2 claims
- 0492US5618700AIL-6 specific monoclonal antibodies, hybridomas therefor and methods of making and using sameYEDA RES & DEV·Filed 1989·Granted Apr 8, 1997·113 cites·5 claims
- 0592US5554513AProduction of recombinant human interferon-beta2YEDA RES & DEV·Filed 1989·Granted Sep 10, 1996·97 cites·24 claims
- 0692US5468608AProduction of interferonYEDA RES & DEV·Filed 1982·Granted Nov 21, 1995·66 cites·5 claims
- 0792US5468607AProduction of interferonYEDA RES & DEV·Filed 1980·Granted Nov 21, 1995·67 cites·9 claims
- 0885US5216128AIFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing itYEDA RES & DEV·Filed 1990·Granted Jun 1, 1993·55 cites·5 claims
- 0983US8809052B2Methods of generating mature oligodendrocytesREVEL MICHEL·Filed 2007·Granted Aug 19, 2014·5 cites·15 claims
- 1078US4889803AProduction of interferon gammaYEDA RES & DEV·Filed 1985·Granted Dec 26, 1989·53 cites·15 claims
- 1177US9404087B2Insulin producing cells derived from pluripotent stem cellsREVEL MICHEL·Filed 2011·Granted Aug 2, 2016·4 cites·19 claims
- 1272US4898891AAntiviral compositionsYEDA RES & DEV·Filed 1987·Granted Feb 6, 1990·46 cites·16 claims
- 1371US7374912B2Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereofYEDA RES & DEV·Filed 2007·Granted May 20, 2008·1 cites·11 claims
- 1471US4808523AConstitutive production of human IFN-β1 by mammalian cells transformed by the IFN-β1 gene fused to an SV40 early promoterYEDA RES & DEV·Filed 1984·Granted Feb 28, 1989·25 cites·11 claims
- 1570US11406670B2Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNSYEDA RES & DEV·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 1667US7824670B2Use of il6r/il6 chimera in nerve cell regenerationYEDA RES & DEV·Filed 2002·Granted Nov 2, 2010·5 cites·6 claims
- 1767US7201896B1IL6RIL6 chimera for the treatment of neurodegenerative diseasesAPPLIED RESEARCH SYSTEMS·Filed 2000·Granted Apr 10, 2007·7 cites·4 claims
- 1866US9631175B2Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNSYEDA RES & DEV·Filed 2014·Granted Apr 25, 2017·0 cites·4 claims
- 1964US8394367B2IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathyREVEL MICHEL·Filed 2005·Granted Mar 12, 2013·1 cites·61 claims
- 2063US11679133B2Methods for differentiating and purifying pancreatic endocrine cellsKADIMASTEM LTD·Filed 2016·Granted Jun 20, 2023·1 cites·6 claims
- 2163US10258651B2Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNSYEDA RES & DEV·Filed 2017·Granted Apr 16, 2019·0 cites·9 claims
- 2262US4378352A(2'-5')Oligo-isoadenylate pharmaceutical compositions and method of useYEDA RES & DEV·Filed 1980·Granted Mar 29, 1983·12 cites·7 claims
- 2361US7264945B2IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferonsYEDA RES & DEV·Filed 2002·Granted Sep 4, 2007·2 cites·11 claims
- 2460US2021054334A1Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)KADIMASTEM LTD·Filed 2019·Application pending·0 cites
- 2558US2023248779A1Methods for differentiating and purifying pancreatic endocrine cellsKADIMASTEM LTD·Filed 2023·Application pending·0 cites
- 2656US7524928B2IFN receptor 1 binding proteinsYEDA RES & DEV·Filed 2006·Granted Apr 28, 2009·0 cites·3 claims
- 2756US7198781B1Chimeric interleukin-6 soluble receptor/ligand proteinsYEDA RES & DEV·Filed 1998·Granted Apr 3, 2007·12 cites·7 claims
- 2856US2020003757A1Method of identifying agents that affect maturation, survival and myelinationKADIMASTEM LTD·Filed 2019·Application pending·0 cites
- 2955US5763210ARecombinant production of interferon-gamma binding proteinsYEDA RES & DEV·Filed 1994·Granted Jun 9, 1998·13 cites·19 claims
- 3054US5047435AAntiviral compositions containing aromatic polycyclic diones and method for treating retrovirus infectionsUNIV NEW YORK·Filed 1989·Granted Sep 10, 1991·16 cites·30 claims
- 3153US5510472AProduction of recombinant human interferon-beta2YEDA RES & DEV·Filed 1992·Granted Apr 23, 1996·15 cites·3 claims
- 3251US4622292AAssay and kit for determining interferonYEDA RES & DEV·Filed 1983·Granted Nov 11, 1986·11 cites·15 claims
- 3351US2014296107A1Method of identifying agents that affect maturation, survival and myelinationREVEL MICHEL·Filed 2012·Application pending·0 cites
- 3450US6172042B1Synthetic peptides that inhibit IL-6 activityYEDA RES & DEV·Filed 1996·Granted Jan 9, 2001·11 cites·25 claims
- 3550US2002119129A1Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferonsYEDA RES & DEV·Filed 2002·Application pending·0 cites
- 3648US2016237404A1Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic laterial sclerosis (als)KADIMASTEM LTD·Filed 2014·Application pending·0 cites
- 3746US5643749ASoluble interferon α-receptor, its preparation and useYEDA RES & DEV·Filed 1994·Granted Jul 1, 1997·7 cites·12 claims
- 3846US2022387514A1Methods of treating acute respiratory distress syndromeKADIMASTEM LTD·Filed 2022·Application pending·0 cites
- 3945US2018230427A1Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic laterial sclerosis (als)KADIMASTEM LTD·Filed 2018·Application pending·0 cites
- 4042US5049589AAntiviral aerosol compositions and pressurized containers containing sameYEDA RES & DEV·Filed 1989·Granted Sep 17, 1991·8 cites·8 claims
- 4141US5902576AAntitumor pharmaceutical composition comprising IL-6 transfected cellsYEDA RES & DEV·Filed 1995·Granted May 11, 1999·6 cites·14 claims
- 4241US5063159AInterferon-induced (2'-5') oligo a synthetase gene, mRNA, cDNA and enzymes having (2'-5') oligo a synthetase activityYEDA RES & DEV·Filed 1986·Granted Nov 5, 1991·5 cites·11 claims
- 4340US8617887B2Method of generating oligodendrocytes from neurosphere cellsREVEL MICHEL·Filed 2004·Granted Dec 31, 2013·0 cites·11 claims
- 4439US5554514AProduction of recombinant human interferon beta2.sbsb.BYEDA RES & DEV·Filed 1991·Granted Sep 10, 1996·3 cites·14 claims
- 4537US4302533ANovel assays for interferonYEDA RES & DEV·Filed 1980·Granted Nov 24, 1981·5 cites·5 claims
- 4635US5071963AInterferon-induced human (2'-5') oligo a synthetaseYEDA RES & DEV·Filed 1987·Granted Dec 10, 1991·4 cites·8 claims
- 4732US5462731AUse of IL-6 for the treatment of chronic lymphocyte leukemia (CLL) and B-cell lymphomasYEDA RES & DEV·Filed 1992·Granted Oct 31, 1995·4 cites·7 claims
- 4830US2017095512A1Methods of inducing myelination and maturation of oligodendrocytesKADIMASTEM LTD·Filed 2015·Application pending·0 cites
- 4924US5358867ADNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferonYEDA RES & DEV·Filed 1993·Granted Oct 25, 1994·1 cites·6 claims
- 5020US5071742AAssay for amoebae and probes for use thereinYEDA RES & DEV·Filed 1989·Granted Dec 10, 1991·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Michel Revel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →